Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate

Thao T. Tang, Quy Le, Sommer Castro, Laura Pardo, Cyd N. McKay, LaKeisha Perkins, Jenny L. Smith, Danielle Kirkey, Cristina L. Abrahams, Kristin Bedard, Arturo Molina, Lisa Eidenshinck Brodersen, Michael R. Loken, Katherine Tarlock, Soheil Meshinchi, Keith R. Loeb